Inhibition of BET Family Proteins Suppresses African Swine Fever Virus Infection
Open Access
- 31 August 2022
- journal article
- research article
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 10 (4) , e0241921
Abstract
Due to the continuing spread of the ASFV in the world and the lack of commercial vaccines, the development of improved control strategies, including antiviral drugs, is urgently needed. BRD4 is an important epigenetic factor and has been commonly used for drug development for tumor treatment.Keywords
All Related Versions
Funding Information
- National Natural Science Foundation of China (32072830)
This publication has 55 references indexed in Scilit:
- In vitro antiviral activity of fluoroquinolones against African swine fever virusVeterinary Microbiology, 2013
- African swine fever virus replication and genomicsVirus Research, 2013
- Identification and utility of innate immune system evasion mechanisms of ASFVVirus Research, 2013
- Pathology of African swine fever: The role of monocyte-macrophageVirus Research, 2013
- Herpes Simplex Viruses: Mechanisms of DNA ReplicationCold Spring Harbor Perspectives in Biology, 2012
- Selective inhibition of CD4 + T-cell cytokine production and autoimmunity by BET protein and c-Myc inhibitorsProceedings of the National Academy of Sciences, 2012
- Disruption of Nuclear Organization during the Initial Phase of African Swine Fever Virus InfectionJournal of Virology, 2011
- Selective inhibition of BET bromodomainsNature, 2010
- Brd4 links chromatin targeting to HPV transcriptional silencingGenes & Development, 2006
- Evolutionary genomics of nucleo-cytoplasmic large DNA virusesVirus Research, 2006